港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

瑞博生物-B

54.850

-0.200-0.36%

成交量：7.50萬

成交額：405.96萬

市值：93.55億

市盈率：-23.10

高：57.100

開：56.000

低：52.200

收：55.050

52周最高：95.800

52周最低：51.200

股本：1.71億

香港流通股本：1.71億

量比：0.43

換手率：0.04%

股息：- -

股息率：- -

每股收益(LYR):-2.374

淨資產收益率：--

總資產收益率：-23.42%

市淨率：-88.09

市盈率(LYR):-23.10

市銷率: 55.72

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

瑞博生物-B

交易所：

SEHK

成立時間：

2007

員工人數：

404

公司地址：

No.168, Yuanfeng Road,Kunshan,Jiangsu Province,China

官網：

http://www.ribolia.com

郵編：

215300

電話：

86 512 57017802

傳真：

- -

簡介：

蘇州瑞博生物技術股份有限公司是一家主要從事小核酸藥物研究和開發，尤其專註於小干擾核酸（siRNA）療法的中國公司。該公司的主營業務是從事小核酸藥物的創新，專註於心血管、代謝類、腎臟和肝病以及其他治療領域。該公司的藥物管線包括RBD4059、RBD5044、RBD7022、RBD7007、RBD2080、RBD1119、RBD1016等。該公司主要在中國國內市場開展業務。

董事

名稱

職位

梁子才

董事會主席，執行董事，戰略委員會主席，薪酬與考核委員會委員

甘黎明

執行董事，戰略委員會委員

張鴻雁

執行董事，提名委員會委員

宇學峰

獨立非執行董事，戰略委員會委員，薪酬與考核委員會委員，提名委員會主席，審計委員會委員

馬朝松

獨立非執行董事，提名委員會委員，審計委員會主席

王瑞平

獨立非執行董事，戰略委員會委員，薪酬與考核委員會主席，審計委員會委員

戚飛

非執行董事，戰略委員會委員

李東方

非執行董事，戰略委員會委員

李宇輝

非執行董事

王番

監事會主席，職工監事

王立傑

監事

張寧

職工監事

股東

名稱

職位

梁子才

首席執行官

張鴻雁

總裁

高山

高級副總裁，首席科學官

張甦

首席財務官，董事會秘書，聯席公司秘書

鍾明輝

聯席公司秘書

首席商務官

甘黎明

聯席首席執行官，全球研發總裁

張寧

高級財務經理

王番

行政副總監

童成

執行副總裁

首席醫學官

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/06938/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"06938","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06938\",,,,,undefined,":{"symbol":"06938","market":"HK","secType":"STK","nameCN":"瑞博生物-B","latestPrice":54.85,"timestamp":1774512495974,"preClose":55.05,"halted":0,"volume":75000,"delay":0,"changeRate":-0.0036330608537692233,"floatShares":170554910,"shares":170554910,"eps":-2.3743836918772545,"marketStatus":"未開盤","change":-0.2,"latestTime":"03-26 16:08:15","open":56,"high":57.1,"low":52.2,"amount":4059580,"amplitude":0.08901,"askPrice":54.9,"askSize":200,"bidPrice":54.85,"bidSize":3800,"shortable":0,"etf":0,"ttmEps":-1.6042361536113696,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1774575000000},"marketStatusCode":0,"adr":0,"listingDate":1767888000000,"exchange":"SEHK","adjPreClose":55.05,"openAndCloseTimeList":[[1774488600000,1774497600000],[1774501200000,1774512000000]],"volumeRatio":0.43044077134986225,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06938\",,,,,undefined,":{"symbol":"06938","floatShares":170554910,"roa":"-23.42%","roe":"--","lyrEps":-2.374341,"volumeRatio":0.43044077134986225,"shares":170554910,"dividePrice":0,"high":57.1,"amplitude":0.08901,"preClose":55.05,"low":52.2,"week52Low":51.2,"pbRate":"-88.09","psRate":"55.72","week52High":95.8,"institutionHeld":0,"latestPrice":54.85,"committee":0.9,"eps":-2.3743408179363565,"divideRate":0,"volume":75000,"delay":0,"ttmEps":-1.604207186125503,"open":56,"prevYearClose":57.97,"prevWeekClose":57.05,"prevMonthClose":68.5,"prevQuarterClose":57.97,"fiveDayClose":56.8,"twentyDayClose":67.2,"sixtyDayClose":57.97},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06938\",params:#limit:5,,,undefined,":[{"date":"2026-03-25","symbol":"06938","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774402200000,"name":null,"time":"","dateTimestamp":1774368000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06938\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06938\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1773417600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06938\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06938","date":"2026-03-25","current":-34.154038,"percent":0.923077,"low":-50.513246,"twenty":-48.38493,"median":-40.573567,"eighty":-38.714579,"high":-35.975036,"avg":-42.456568,"sd":4.509362,"marketCap":9389047795},"quantilePoints":[{"date":"2026-02-13","current":-47.784644,"twenty":-49.967526,"median":-49.148945,"eighty":-48.330365,"marketCap":11947371445},{"date":"2026-02-20","current":-49.493094,"twenty":-49.901155,"median":-49.02522,"eighty":-48.248265,"marketCap":12356703229},{"date":"2026-02-27","current":-46.28708,"twenty":-49.778496,"median":-48.557346,"eighty":-47.185619,"marketCap":11683011335},{"date":"2026-03-06","current":-41.043234,"twenty":-48.963884,"median":-47.035862,"eighty":-41.420692,"marketCap":10275933327},{"date":"2026-03-13","current":-37.939269,"twenty":-48.578839,"median":-43.677981,"eighty":-39.627323,"marketCap":9542547214},{"date":"2026-03-20","current":-38.832211,"twenty":-48.543939,"median":-40.85279,"eighty":-39.405242,"marketCap":9730157615},{"date":"2026-03-25","current":-37.550977,"twenty":-48.38493,"median":-40.573567,"eighty":-38.714579,"marketCap":9389047795}],"updateTime":1774519883755},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":243319843,"yearFounded":2007,"employeeNum":404,"address":"No.168, Yuanfeng Road,Kunshan,Jiangsu Province,China","zipCode":"215300","officePhone":"86 512 57017802"},"stockCompanyDetail":{"websiteUrl":"http://www.ribolia.com","stockEarnings":[{"period":"1week","weight":-0.0343},{"period":"1month","weight":-0.2329},{"period":"3month","weight":-0.0538},{"period":"ytd","weight":-0.0538}],"compareEarnings":[{"period":"1week","weight":-0.0253},{"period":"1month","weight":-0.0652},{"period":"3month","weight":-0.0373},{"period":"6month","weight":-0.0487},{"period":"1year","weight":0.0585},{"period":"ytd","weight":-0.0302}],"compareStock":{"symbol":"HSI","name":"恆生指數"},"description":"蘇州瑞博生物技術股份有限公司是一家主要從事小核酸藥物研究和開發，尤其專註於小干擾核酸（siRNA）療法的中國公司。該公司的主營業務是從事小核酸藥物的創新，專註於心血管、代謝類、腎臟和肝病以及其他治療領域。該公司的藥物管線包括RBD4059、RBD5044、RBD7022、RBD7007、RBD2080、RBD1119、RBD1016等。該公司主要在中國國內市場開展業務。","exchange":"SEHK","name":"瑞博生物-B","nameEN":"RIBOLIFE-B"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"06938\",market:\"HK\",,,undefined,":{"directors":[{"name":"梁子才","position":"董事會主席，執行董事，戰略委員會主席，薪酬與考核委員會委員"},{"name":"甘黎明","position":"執行董事，戰略委員會委員"},{"name":"張鴻雁","position":"執行董事，提名委員會委員"},{"name":"宇學峰","position":"獨立非執行董事，戰略委員會委員，薪酬與考核委員會委員，提名委員會主席，審計委員會委員"},{"name":"馬朝松","position":"獨立非執行董事，提名委員會委員，審計委員會主席"},{"name":"王瑞平","position":"獨立非執行董事，戰略委員會委員，薪酬與考核委員會主席，審計委員會委員"},{"name":"戚飛","position":"非執行董事，戰略委員會委員"},{"name":"李東方","position":"非執行董事，戰略委員會委員"},{"name":"李宇輝","position":"非執行董事"},{"name":"王番","position":"監事會主席，職工監事"},{"name":"王立傑","position":"監事"},{"name":"張寧","position":"職工監事"}],"executives":[{"name":"梁子才","position":"首席執行官"},{"name":"張鴻雁","position":"總裁"},{"name":"高山","position":"高級副總裁，首席科學官"},{"name":"張甦","position":"首席財務官，董事會秘書，聯席公司秘書"},{"name":"鍾明輝","position":"聯席公司秘書"},{"position":"首席商務官"},{"name":"甘黎明","position":"聯席首席執行官，全球研發總裁"},{"name":"張寧","position":"高級財務經理"},{"name":"王番","position":"行政副總監"},{"name":"童成","position":"執行副總裁"},{"position":"首席醫學官"}]}}}